ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Rejuran aggressively marketed with large billboard advertisements at Incheon International Airport duty-free shops

By: Get News
Duty-free marketing over the Southeast Asia's 'April Golden Holiday'… also present 'Korean Edition' of Rejuran Cosmetics

With Korean duty-free sales exceeding 1 trillion won after the end of the pandemic in February, the distribution industry is attracting tourists for the Southeast Asian holidays, Holy Week in the Philippines and Thai Songkran.

PharmaResearch's brand "Rejuran Cosmetics · Inner Dot" will also launch a large-scale marketing campaign in Incheon International Airport's Terminal 1 duty-free zone in line with this demand.

"Rejuran Cosmetics · Inner Dot" will showcase product descriptions and demonstrations through "influencer livestreams" in each country. The event will introduce Rejuran products directly on social media platforms such as Weibo, WeChat, and Instagram. This will help connect potential customers in China, Southeast Asia, and Japan, ultimately leading to sales.

In addition to cosmetics, Japanese and Southeast Asian customers interested in inner beauty will also be introduced to Rejuran Inner Dot Jelly. "Rejuran Inner Dot" is the first inner beauty product from PharmaResearch, containing three elements of the dermis (collagen, elastin, and hyaluronic acid) and salmon DNA in one packet. The product's green grape and apple flavor make it a great option for an everyday snack that customers can enjoy.

According to officials from duty-free shops, "the market for duty-free items is expanding beyond cosmetics and now includes a focus on inner beauty...as the demand for skin health foods and functional foods around young people increases, the inner beauty market will continue to grow."

Rejuran Cosmetics' "Korean edition" package is available at the Grand Duty-Free store in Terminal 1. The package includes Rejuran's signature products, "Turnover Ample" and "Turnover Dual Effect Ample," upgraded with a Korean design to promote Korean beauty.

A PharmaResearch official stated, "The surge in duty-free shop sales that began with issuing short-term visas for Chinese visitors has now been further boosted by the increased visitors from Southeast Asia, resulting in significant sales growth. The company had already aimed to expand the market in Southeast Asian countries since before the COVID-19 pandemic, and we will actively use various content such as influencer broadcasting and product demonstration to attract more sales."

PharmaResearch is a pharmaceutical and biotechnology company based on regenerative medicine that manufactures and distributes pharmaceutical products, medical equipment, cosmetic products, and functional foods, primarily DOT™ PDRN and DOT™ PN, which are materials for tissue regeneration. Representative products include Rejuran®, Conjuran®, Rejuran Cosmetics, Re-an® eye drops, and Rejuderma®.

Media Contact
Company Name: Pharmaresearch
Contact Person: Seulki Kwak
Email: Send Email
Country: South Korea
Website: http://pharmaresearch.co.kr/kor/



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.